JuLib | Articles & more - {"Pathophysiological Mechanisms of Neurological and Psychiatric Diseases"}

1

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

2

Abstract

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

3

Contribution to a conference proceedings
Journal Article

NI-19. The use of dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine-PET in the clinical evaluation of brain tumors in children and adolescents

Dunkl, Veronika
2014

Neuro-Oncology, 16 (2014) S. v138-v158

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

4

Journal Article

Comparison of $^{18}$F-FET PET and perfusion weighted MR imaging: a PET-MR imaging hybrid study in patients with brain tumors.

Filss, Christian
2014

Journal of Nuclear Medicine Journal of nuclear medicine, 55 55 (2014 2014) 4 4, S. 540-545 540-545

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

5

Poster

Role of [18F]fluoroethyl-L-tyrosine PET as diagnostic tool for malignant transformation in patients with low-grade glioma.

Galldiks, Norbert
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

6

Journal Article

“One week on–one week off”: efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center

Galldiks, Norbert
2013

Journal of neuro-oncology, 112 (2013) 2, S. 209 - 215

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

7

Contribution to a conference proceedings

The use of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, Norbert
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

8

Poster

The use of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, Norbert
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

9

Conference Presentation

Role of [18F]fluoroethyl-L-tyrosine PET as diagnostic tool for malignant transformation in patients with low-grade glioma.

Galldiks, Norbert
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

10

Conference Presentation

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the clinical evaluation of brain tumors in children and young adults.

Dunkl, Veronika
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

11

Contribution to a conference proceedings
Journal Article

Volumetry of [11C]-methionine PET uptake as a prognostic marker before treatment of patients with malignant glioma

Dunkl, Veronika
2012

European journal of neurology, 19 (2012) S. 63

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

12

Journal Article

Volumetry of [¹¹C]-methionine positron emission tomographic uptake as a prognostic marker before treatment of patients with malignant glioma.

Galldiks, Norbert
2012

Molecular imaging: official publication of the Society for Molecular Imaging, 11 (2012) 6, S. 516-527

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

Narrow Search Results